Standard chemotherapy with or without bevacizumab in advanced ovarian cancer: quality-of-life outcomes from the International Collaboration on Ovarian Neoplasms (ICON7) phase 3 randomised trial

Dan Stark, Matthew Nankivell, Eric Pujade-lauraine, Gunnar Kristensen, Lorraine Elit, Martin Stockler, Felix Hilpert, Andrés Cervantes, Julia Brown, Anne Lanceley, Galina Velikova, Eduardo Sabate, Jacobus Pfisterer, Mark S Carey, Philip Beale, Wendi Qian, Ann Marie Swart, Amit Oza, Tim Perren

Research output: Contribution to journalArticlepeer-review

118 Citations (Scopus)
Original languageEnglish
Pages (from-to)236-243
JournalThe Lancet Oncology
Issue number3
Publication statusPublished - 1 Mar 2013

Cite this